Kalium Chloratum Pm

Potassium chloride, the active ingredient in Kalium Chloratum Pm, is an electrolyte supplement presented as an intravenous solution for intravenous use. It is employed to correct hypokalemia and to provide potassium replacement therapy in patients who require rapid restoration of electrolyte balance, such as those on diuretics or with cardiac conditions, or after major surgery, under medical supervision.

GNH USA supplies Kalium Chloratum Pm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and with reliable logistics across multiple continents worldwide.

Kalium Chloratum Pm, an intravenous potassium chloride solution, is used in the management of electrolyte disorders related to low potassium levels.

- Hypokalemia: restores serum potassium to normal ranges, reducing risk of cardiac arrhythmias. - Diuretic‑induced potassium loss: replaces potassium lost during loop or thiazide diuretic therapy. - Post‑operative potassium depletion: corrects potassium deficits after surgery or trauma. - Renal tubular acidosis type 1: provides potassium supplementation as part of acid‑base correction.

Intravenous potassium chloride may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Pain or irritation at the infusion site - Nausea or vomiting - Transient hypotension

Serious or Rare Side Effects: - Hyperkalemia causing cardiac arrhythmia - Ventricular fibrillation or cardiac arrest - Severe allergic reaction (anaphylaxis)

When using Kalium Chloratum Pm, several precautions should be observed to ensure patient safety and product integrity.

- Assess serum potassium: confirm hypokalemia and baseline levels before infusion. - Infuse slowly: administer over at least 10‑20 minutes to reduce risk of cardiac events. - Monitor cardiac rhythm: continuous ECG monitoring is recommended during and after infusion. - Avoid in patients with severe renal impairment: reduced excretion may cause accumulation. - Contraindicated in hyperkalemia: do not administer if serum potassium exceeds normal range. - Store below 25°C: keep in original container, protect from light and moisture.

Potassium chloride can interact with several medications, altering potassium balance or cardiac risk.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may cause additive hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of dangerous potassium elevation. - Trimethoprim‑sulfamethoxazole: can raise serum potassium levels.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce renal potassium excretion. - Digoxin: heightened risk of digoxin toxicity with hyperkalemia. - Beta‑blockers: may mask symptoms of hypoglycemia and affect potassium handling.